EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation

Alexander Popov iD, Nikita Suvorov iD, Mariia Larkina iD, Evgenii Plotnikov iD, Ruslan Varvashenya, Vitalina Bodenko, Gleb Yanovich, Petr Ostroverkhov iD, Maxim Usachev, Elena Filonenko, Mikhail Belousov iD, Mikhail Grin

Molecules · 2024

DOI: 10.3390/molecules30010117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Alexander Popov und 11 weiteren Autor:innen. Beteiligte Einrichtung: M. V. Lomonosov Institute of Fine Chemical Technology, MIREA-Russian Technological University, 86 Vernadsky Av., 119571 Moscow, Russia. Hauptthemen laut MEDLINE: Porphyrins, Radiopharmaceuticals, Technetium, Nicotinic Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIREA - Russian Technological University, RTU MIREA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of radiopharmaceuticals for diagnostics in oncology allows for the detection of the disease at an early stage. Among diagnostic radionuclides, 99mTc is a promising isotope that has been used to create several drugs for clinical use. One of the most effective 99mTc chelators is 6-hydrazinylnicotinic acid (HYNIC), which, when combined with various vector molecules, can be used for targeted delivery of radionuclides to tumor tissues. At the same time, it is known that tetrapyrrole macrocycles are capable of selective accumulation in tumors, and thus can be used to target radiopharmaceuticals with 99mTc. In this work, the conjugate of natural chlorin and HYNIC was obtained, and preliminary preclinical studies were carried out on its radiocomplex with 99mTc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PorphyrinsRadiopharmaceuticalsTechnetiumNicotinic AcidsOrganotechnetium CompoundsAnimalsHumansMiceTissue DistributionIsotope Labeling

Stichwörter der Autor:innen

HYNICcancerchlorinradiopharmaceuticalstechnetium-99m

Substanzen

PorphyrinschlorinRadiopharmaceuticalsTechnetiumNicotinic AcidsOrganotechnetium Compounds

Autor:innen und Institutionen

  • M. V. Lomonosov Institute of Fine Chemical Technology, MIREA-Russian Technological University, 86 Vernadsky Av., 119571 Moscow, Russia.
  • Science and Education Laboratory for Chemical and Pharmaceutical Research, Siberian State Medical University, 634050 Tomsk, Russia.
  • Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • P. A. Hertsen Moscow Oncology Research Center, 125284 Moscow, Russia.
  • Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia.

ORCID-Profile: Alexander Popov, Nikita Suvorov, Mariia Larkina, Evgenii Plotnikov, Petr Ostroverkhov, Mikhail Belousov

Förderung

  • MIREA - Russian Technological University
  • RTU MIREA

Zitieren

APA

Popov, A., Suvorov, N., Larkina, M., Plotnikov, E., Varvashenya, R., Bodenko, V., Yanovich, G., Ostroverkhov, P., Usachev, M., Filonenko, E., Belousov, M., & Grin, M. (2024). Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation. Molecules. https://doi.org/10.3390/molecules30010117

Vancouver

Popov A, Suvorov N, Larkina M, Plotnikov E, Varvashenya R, Bodenko V, et al. Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation. Molecules. 2024. doi:10.3390/molecules30010117

BibTeX
@article{Popov2024,
  author = {Popov, Alexander and Suvorov, Nikita and Larkina, Mariia and Plotnikov, Evgenii and Varvashenya, Ruslan and Bodenko, Vitalina and Yanovich, Gleb and Ostroverkhov, Petr and Usachev, Maxim and Filonenko, Elena and Belousov, Mikhail and Grin, Mikhail},
  title = {Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules30010117}
}
Kostenlos starten →